Member Info for ogm4

No need for freezer storage will definitely be a winner in terms of speed and efficiency.

New post:

https://x.com/genedriveplc/status/1825510215229333965

Global stroke figures:

https://www.world-stroke.org/world-stroke-day-campaign/about-stroke/impact-of-stroke#:~:text=Stroke%20is%20a%20leading%20cause,a%20stroke%20in%20their%20lifetime.&text=Over%2012%20million%20people%20worldwide,the%20world%20have%20experienced%20stroke.

The recent Director's buys will cause continuous underlying buying pressure in the near term imo.

What about the other few large buys (?) yesterday afternoon?...

Directors buys..... tick

Increased PR...... tick

Ian Gilham

Ph.D., Non-Executive Chairman

Ian was appointed a Director on 24 November 2014 and as Non-Executive Chairman on 11 May 2015. He is currently Chair of Trustees for LifeArc, a philanthropic fund looking to invest £1.3 billion making life science life changing; Non-Executive Chairman of at Pelago Bioscience AB, a Life Science tools business based in Stockholm; and Non-Executive Chairman of RevoNA Bio Ltd, a University of Portsmouth spinout Life Science tools company. Dr Gilham was formerly Chief Executive Officer of Axis-Shield Plc.

Indication of strong confidence by the Board!...

1 million buy from Dr. Gilham yesterday

Bodes well!...

Genedrive are thrilled to be exhibiting at POCT Innovators: The Power To Disrupt Clinical EXPO!

----------------------------------------------------

Could be a good showcase for both Genedrive's products to NHS management and the wider medical community.

Genedrive are thrilled to be exhibiting at POCT Innovators: The Power To Disrupt Clinical EXPO!

The event will be held on Monday 16th September 2024 at 15 Hatfields Conference Centre, in London.

Join us in #London for our next face to face meeting where a wide range of hot topics in this sector will be discussed.

Attendance is free to NHS and academic delegates with NHS or academic email addresses, but places are limited due to the venue size.

So don’t delay book your place today via the POCTInnovators website.

#GDR #POCT #pointofcare #diagnostics #medtech #lifesciences #medicaldevices #pointofcaretesting #healthcare #innovation #pharmacogenomics #pharmacogenetics

Just came back from work today without any internet connection, but what a nice RNS surprise this morning to start off this week!... A fundamental game changer achieving the first UK commercial sales of the Genedrive® CYP2C19-ID Kit to the largest stroke center in England with more than 2,000 stroke patient admissions per year.

Meanwhile I had asked the company over the weekend to update the CEO profile on their website as the former CEO was still being displayed. However, I just checked again and the profile has been updated today showing the new CEO, Dr. Gino Miele. Let's bring in some more commercial orders!

The new CEO Gino is just on seat indeed and slowly but surely the PR machine has started to gain momentum this week. Note the wording of "significant" monetary cost savings and better health outcome. All eyes on the next commercial orders arriving - both domestic and overseas.

....

"Both interventional products have been recognised & recommended by the UK National Institute for Clinical Care and Excellence for use in the UK NHS, offering significant potential monetary savings to healthcare systems and significantly better health outcomes for patients.

I’m thrilled to be leading the fantastic team at genedrive into our next phase of development; growth and commercialisation, and ultimately providing positive benefits to patients worldwide.”

Enedrive plc (AIM: GDR), the point of care Pharmacogenetic testing company, announces that initial orders of the Genedrive® MT-RNR1 products have been received from France, Austria, Greece, Saudi Arabia, Turkey and the Netherlands.

That's at least another 6 machines from overseas, but could be in the tens, who knows...

'Unsustainable’: UK predicted to see 50% spike in strokes by 2035

Stark new projections suggest annual admissions will rise to 151,000, costing the NHS and economy £75bn

Andrew Gregory Health editor

Thu 25 Apr 2024 19.01 EDT

https://www.theguardian.com/society/2024/apr/26/unsustainable-uk-predicted-to-see-50-spike-in-strokes-by-2035

5 min ago

https://x.com/genedriveplc/status/1821571940190171207

The market is waking up to GDR's potential!...

Two great products in the pipeline, expecting more sales news to follow shortly as previouly indicated by the company.

DYOR

I noticed on Dr. Miele's LinkedIn profile he received some great, impressive recommendations from people in the industry, which is definitely reassuring.

Or he got a better offer elsewhere, who knows.

Indeed, it might be a simple reason.

Maybe James was always deemed to be the interim manager for a short while covering